Who owns Liminatus Pharma, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Liminatus Pharma, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Samda Biolab Co., LTD. (filed 2026-07-22).

Who is behind it

Liminatus Pharma, Inc.: incorporated in Delaware; business address in Cerritos, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G, 2026-07-22).

Officers and directors, each with the role and the filing that names them:

• Chris Kim: Executive Officer, Director (Form D, 2026-06-18)
• Scott Dam: Executive Officer (Form D, 2026-06-18)
• Byong C. Yoo: Executive Officer (Form D, 2026-06-18)
• Sang-jin Daniel Lee: Executive Officer (Form D, 2026-06-18)
• Beom K. Choi: Executive Officer (Form D, 2026-06-18)
• Eun Sook Lee: Director (Form D, 2026-06-18)
• Nicholas Fernandez: Director (Form D, 2026-06-18)
• Ji Yeon Baek: Director (Form D, 2026-06-18)

Money raised

Latest IPO step: Liminatus Pharma, Inc. filed to go public (S-1, 2026-06-24).

IPO filings: S-1, 2026-06-24, 424B4, 2026-02-18, S-1, 2026-02-11, S-1/A, 2025-07-28, S-1, 2025-06-24; ticker LIMN on Nasdaq Global Market.

Acquisitions reported on Form 8-K, Item 2.01: acquired InnocsAI LLC (2026-07-06).

Related pages

5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.